Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Xu, Lu ^a   Ping, Fan ^a   Yin, Jinhua ^a   Xiao, Xinhua ^a   Xiang, Hongding ^a   Ballantyne, Christie M ^b,c   Wu, Huaizhu ^b   Li, Ming ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; FIBROBLAST GROWTH FACTOR 21; INSULIN; OSTEONECTIN; PROINSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES, GESTATIONAL; DYSLIPIDEMIAS; FASTING; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; OSTEONECTIN; PREGNANCY; PROINSULIN; TRIGLYCERIDES;

EID: 84892610383     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081615     Document Type: Article

References (38)

1. American Diabetes Associateion (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30 Suppl 1: S42-47.
2. Ferrara A (2007) Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30 Suppl 2: S141-146.
3. Carpenter MW (2007) Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 30 Suppl 2: S246-250.
4. Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, et al. (2009) Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 201: 482 e481-488.
5. Greenberg AS, McDaniel ML (2002) Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32 Suppl 3: 24-34.
6. Calle MC, Fernandez ML (2012) Inflammation and type 2 diabetes. Diabetes Metab 38: 183-191.
7. Miehle K, Stepan H, Fasshauer M (2012) Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) 76: 2-11.
8. Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, et al. (2006) Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 91: 4137-4143.
9. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, et al. (1981) Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26: 99-105.
10. Bornstein P (1995) Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 130: 503-506.
11. Kos K, Wong S, Tan B, Gummesson A, Jernas M, et al. (2009) Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose. Diabetes 58: 1780-1788.
12. Lee DE, Kehlenbrink S, Lee H, Hawkins M, Yudkin JS (2009) Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 296: E1210-1229.
13. Munjal ID, McLean NV, Grant MB, Blake DA (1994) Differences in the synthesis of secreted proteins in human retinal endothelial cells of diabetic and nondiabetic origin. Curr Eye Res 13: 303-310.
14. Kanauchi M, Nishioka M, Dohi K (2000) Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury. Diabetologia 43: 1076-1077.
15. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, et al. (2003) Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14: 968-980.
16. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, et al. (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115: 1627-1635.
17. Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, et al. (2006) Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55: 2470-2478.
18. Stein S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, et al. (2010) Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism 59: 33-37.
19. Tan BK, Sivakumar K, Bari MF, Vatish M, Randeva HS (2013) Lower cerebrospinal fluid/plasma fibroblast growth factor 21 (FGF21) ratios and placental FGF21 production in gestational diabetes. PLoS One 8: e65254.
20. Ping F, Xiang HD, Li M, Li W, Liu JT, et al. (2012) Effects of variation in retinol binding protein 4 gene and adipose specific expression of gestational diabetes in Beijing, China. Diabetes Res Clin Pract 97: 283-289.
21. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
22. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM (2001) Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 24: 1602-1607.
23. Ming L, Jing Y, Congyuan W, Kui Z (1999) A monoclonal antibody-based sandwich enzymeimmunoassay for human serum proinsulin. Chinese Journal of Diabetes 3: 157-159.
24. Li M, Fisette A, Zhao XY, Deng JY, Mi J, et al. (2009) Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes (Lond) 33: 424-439.
25. Xu L, Li M, Yin J, Cheng H, Yu M, et al. (2012) Change of Body Composition and Adipokines and Their Relationship with Insulin Resistance across Pubertal Development in Obese and Nonobese Chinese Children: The BCAMS Study. Int J Endocrinol 2012: 389108. doi: 10.1155/2012/389108.
26. Wu D, Li L, Yang M, Liu H, Yang G (2011) Elevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus. Eur J Endocrinol 165: 597-601.
27. Jiang Y, Zhu Y, Shi Y, He Y, Kuang Z, et al. (2013) Downregulation of SPARC expression inhibits the invasion of human trophoblast cells in vitro. PLoS One 8: e69079.
28. Harries LW, McCulloch LJ, Holley JE, Rawling TJ, Welters HJ, et al. (2013) A role for SPARC in the moderation of human insulin secretion. PLoS One 8: e68253.
29. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, et al. (2009) Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 29: 1575-1591.
30. Nie J, Sage EH (2009) SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J Biol Chem 284: 1279-1290.
31. Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, et al. (2000) Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 101: 477-484.
32. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
33. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, et al. (2003) First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26: 819-824.
34. Wolf M, Sauk J, Shah A, Vossen Smirnakis K, Jimenez-Kimble R, et al. (2004) Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 27: 21-27.
35. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, et al. (2008) Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9: R14.
36. Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, Prikoszovich T, Steiner H, et al. (2008) The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab 93: 1689-1695.
37. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302: 179-188.
38. Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, et al. (2007) Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes. Diabet Med 24: 245-252.